FR
Upload

Turing Pharmaceuticals CEO defends Daraprim price hike

CBS This Morning 90,21490K
67,652 views
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.
Published on Sep 22, 2015

When Turing Pharmaceuticals bought a 62-year-old drug called Daraprim in August, the company immediately raised the price of one pill from $13.50 to $750. The increase drew protests in the medical community from those concerned that many patients will no longer be able to afford the drug. Don Dahler spoke to Turing CEO Martin Shkreli, who says the movie is simply a smart business decision.

When autoplay is enabled, a suggested video will automatically play next.

Up Next

to add this to Watch Later

Add to